{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:07:47Z","timestamp":1760234867959,"version":"build-2065373602"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004172","name":"Mersin \u00dcniversitesi","doi-asserted-by":"publisher","award":["2023-2-TP3-4963"],"award-info":[{"award-number":["2023-2-TP3-4963"]}],"id":[{"id":"10.13039\/501100004172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"DOI":"10.1007\/s12223-025-01357-2","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:22:33Z","timestamp":1760163753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the interaction and synergy potential of bedaquiline and clarithromycin in combination with efflux pump inhibitors in clinical isolates of Mycobacterium abscessus complex"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7232-5111","authenticated-orcid":false,"given":"Esra G\u00fcl","family":"Tursun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7094-4838","authenticated-orcid":false,"given":"Taylan","family":"Bozok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-570X","authenticated-orcid":false,"given":"Can","family":"Bi\u00e7men","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1221-7907","authenticated-orcid":false,"given":"G\u00f6n\u00fcl","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"1357_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01919-18","volume":"63","author":"BA Brown-Elliott","year":"2019","unstructured":"Brown-Elliott BA, Wallace RJ (2019) In vitro susceptibility testing of bedaquiline against Mycobacterium abscessus complex. Antimicrob Agents Chemother 63:e01919\u201318. https:\/\/doi.org\/10.1128\/aac.01919-18","journal-title":"Antimicrob Agents Chemother"},{"key":"1357_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s15010-024-02183-3","volume":"52","author":"A Calcagno","year":"2024","unstructured":"Calcagno A, Coppola N, Sarmati L, Tadolini M, Parrella R, Matteelli A et al (2024) Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine. Infection 52:737\u2013765. https:\/\/doi.org\/10.1007\/s15010-024-02183-3","journal-title":"Infection"},{"key":"1357_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/futurepharmacol3030041","volume":"3","author":"M Cocorullo","year":"2023","unstructured":"Cocorullo M, Bettoni C, Foiadelli S, Stelitano G (2023) Moles of molecules against Mycobacterium abscessus: a review of current research. Future Pharmacol 3:637\u2013663","journal-title":"Future Pharmacol"},{"key":"1357_CR4","doi-asserted-by":"crossref","unstructured":"Garcia LS (2010) Synergism testing: broth microdilution checkerboard and broth macrodilution methods. https:\/\/api.semanticscholar.org\/CorpusID:99352577.\u00a0Accessed 16 Feb 2025","DOI":"10.1128\/9781555817435.ch5.12"},{"key":"1357_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/idr.S239850","volume":"13","author":"Q Guo","year":"2020","unstructured":"Guo Q, Chen J, Zhang S, Zou Y, Zhang Y, Huang D et al (2020) Efflux pumps contribute to intrinsic clarithromycin resistance in clinical, Mycobacterium abscessus isolates. Infect Drug Resist 13:447\u2013454. https:\/\/doi.org\/10.2147\/idr.S239850","journal-title":"Infect Drug Resist"},{"key":"1357_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4046\/trd.2018.0026","volume":"82","author":"D Jeon","year":"2019","unstructured":"Jeon D (2019) Infection source and epidemiology of nontuberculous mycobacterial lung disease. Tuberc Respir Dis (Seoul) 82:94\u2013101. https:\/\/doi.org\/10.4046\/trd.2018.0026","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"1357_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00665-19","volume":"63","author":"DH Kim","year":"2019","unstructured":"Kim DH, Jhun BW, Moon SM, Kim SY, Jeon K, Kwon OJ et al (2019) In vitro activity of bedaquiline and delamanid against nontuberculous mycobacteria, including macrolide-resistant clinical isolates. Antimicrob Agents Chemother 63:e00665\u201319. https:\/\/doi.org\/10.1128\/aac.00665-19","journal-title":"Antimicrob Agents Chemother"},{"key":"1357_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3348\/kjr.2002.3.3.145","volume":"3","author":"WJ Koh","year":"2002","unstructured":"Koh WJ, Kwon OJ, Lee KS (2002) Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients. Korean J Radiol 3:145\u2013157. https:\/\/doi.org\/10.3348\/kjr.2002.3.3.145","journal-title":"Korean J Radiol"},{"key":"1357_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7030090","volume":"7","author":"RC Lopeman","year":"2019","unstructured":"Lopeman RC, Harrison J, Desai M, Cox JAG (2019) Mycobacterium abscessus: environmental bacterium turned clinical nightmare. Microorganisms 7:90. https:\/\/doi.org\/10.3390\/microorganisms7030090","journal-title":"Microorganisms"},{"key":"1357_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02179","volume":"9","author":"S Luthra","year":"2018","unstructured":"Luthra S, Rominski A, Sander P (2018) The role of antibiotic-target-modifying and antibiotic-modifying enzymes in Mycobacterium abscessus drug resistance. Front Microbiol 9:2179. https:\/\/doi.org\/10.3389\/fmicb.2018.02179","journal-title":"Front Microbiol"},{"key":"1357_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/ijmy.ijmy_181_19","volume":"9","author":"A Martin","year":"2020","unstructured":"Martin A, Bouyakoub Y, Soumillion K, Mantu EN, Colmant A, Rodriguez-Villalobos H (2020) Targeting bedaquiline mycobacterial efflux pump to potentially enhance therapy in Mycobacterium abscessus. Int J Mycobacteriol 9:71\u201375. https:\/\/doi.org\/10.4103\/ijmy.ijmy_181_19","journal-title":"Int J Mycobacteriol"},{"key":"1357_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3892\/etm.2019.8289","volume":"19","author":"A Mase","year":"2020","unstructured":"Mase A, Yamaguchi F, Funaki T, Yamazaki Y, Shikama Y, Fukuchi K (2020) PCR amplification of the erm(41) gene can be used to predict the sensitivity of Mycobacterium abscessus complex strains to clarithromycin. Exp Ther Med 19:945\u2013955. https:\/\/doi.org\/10.3892\/etm.2019.8289","journal-title":"Exp Ther Med"},{"key":"1357_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1380848","volume":"15","author":"J Mi","year":"2024","unstructured":"Mi J, Wu X, Liang J (2024) The advances in adjuvant therapy for tuberculosis with immunoregulatory compounds. Front Microbiol 15:1380848. https:\/\/doi.org\/10.3389\/fmicb.2024.1380848","journal-title":"Front Microbiol"},{"key":"1357_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jgar.2022.10.015","volume":"31","author":"SE Mudde","year":"2022","unstructured":"Mudde SE, Schildkraut JA, Ammerman NC, de Vogel CP, de Steenwinkel JEM, van Ingen J, Bax HI (2022) Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps. J Glob Antimicrob Resist 31:345\u2013352. https:\/\/doi.org\/10.1016\/j.jgar.2022.10.015","journal-title":"J Glob Antimicrob Resist"},{"key":"1357_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00681","volume":"8","author":"MJ Nasiri","year":"2017","unstructured":"Nasiri MJ, Haeili M, Ghazi M, Goudarzi H, Pormohammad A, Imani Fooladi AA, Feizabadi MM (2017) New insights in to the intrinsic and acquired drug resistance mechanisms in mycobacteria. Front Microbiol 8:681. https:\/\/doi.org\/10.3389\/fmicb.2017.00681","journal-title":"Front Microbiol"},{"key":"1357_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1331508","volume":"15","author":"TQ Nguyen","year":"2024","unstructured":"Nguyen TQ, Heo BE, Jeon S, Ash A, Lee H, Moon C, Jang J (2024) Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches. Front Microbiol 15:1331508. https:\/\/doi.org\/10.3389\/fmicb.2024.1331508","journal-title":"Front Microbiol"},{"key":"1357_CR17","doi-asserted-by":"publisher","unstructured":"Phua ZY, Li M, Ali A, Cheong CCS, Goh KJ, Seto MYK et al (2024) A potent verapamil analog targeting membrane energetics in mycobacteria. Available at SSRN 4958835. https:\/\/doi.org\/10.2139\/ssrn.4958835","DOI":"10.2139\/ssrn.4958835"},{"key":"1357_CR18","doi-asserted-by":"publisher","unstructured":"Puk K, Guz L (2022) Effect of alkaloid berberine on the susceptibility of nontuberculous mycobacteria to antibiotics. Pol J Vet Sci 25:479\u2013481. https:\/\/doi.org\/10.24425\/pjvs.2022.142034","DOI":"10.24425\/pjvs.2022.142034"},{"key":"1357_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124191","volume":"21","author":"L Rindi","year":"2020","unstructured":"Rindi L (2020) Efflux pump inhibitors against nontuberculous mycobacteria. Int J Mol Sci 21:4191. https:\/\/doi.org\/10.3390\/ijms21124191","journal-title":"Int J Mol Sci"},{"key":"1357_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4046\/trd.2016.79.2.74","volume":"79","author":"YJ Ryu","year":"2016","unstructured":"Ryu YJ, Koh WJ, Daley CL (2016) Diagnosis and treatment of nontuberculous mycobacterial lung disease: clinicians\u2019 perspectives. Tuberc Respir Dis (Seoul) 79:74\u201384. https:\/\/doi.org\/10.4046\/trd.2016.79.2.74","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"1357_CR21","unstructured":"Schildkraut J, Coolen J, Ruesen C, van den Heuvel J, Edo Ace\u00f1a L, Wertheim H et al (2023) The role of metabolic shifts and drug transporters in the response of M. avium to antibiotic exposure. Jodie Anne Schildkraut: 115. https:\/\/hdl.handle.net\/2066\/288649.\u00a0Accessed 18 Feb 2025"},{"key":"1357_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.923968","volume":"10","author":"Q Sun","year":"2022","unstructured":"Sun Q, Yan J, Liao X, Wang C, Wang C, Jiang G et al (2022) Trends and species diversity of non-tuberculous mycobacteria isolated from respiratory samples in Northern China, 2014\u20132021. Front Public Health 10:923968. https:\/\/doi.org\/10.3389\/fpubh.2022.923968","journal-title":"Front Public Health"},{"key":"1357_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082541","volume":"9","author":"K To","year":"2020","unstructured":"To K, Cao R, Yegiazaryan A, Owens J, Venketaraman V (2020) General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus. J Clin Med 9:2541. https:\/\/doi.org\/10.3390\/jcm9082541","journal-title":"J Clin Med"},{"key":"1357_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8030153","volume":"8","author":"JS Vianna","year":"2019","unstructured":"Vianna JS, Machado D, Ramis IB, Silva FP, Bierhals DV, Abril MA et al (2019) The contribution of efflux pumps in Mycobacterium abscessus complex resistance to clarithromycin. Antibiotics 8:153. https:\/\/doi.org\/10.3390\/antibiotics8030153","journal-title":"Antibiotics"},{"key":"1357_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01714-22","volume":"10","author":"N Wetzstein","year":"2022","unstructured":"Wetzstein N, Diricks M, Kohl TA, Wichelhaus TA, Andres S, Paulowski L et al (2022) Molecular epidemiology of Mycobacterium abscessus isolates recovered from German cystic fibrosis patients. Microbiol Spectr 10:e0171422. https:\/\/doi.org\/10.1128\/spectrum.01714-22","journal-title":"Microbiol Spectr"},{"key":"1357_CR26","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.2147\/idr.S431256","volume":"16","author":"H Zhou","year":"2023","unstructured":"Zhou H, Wang W, Cai L, Yang T (2023) Potentiation and mechanism of berberine as an antibiotic adjuvant against multidrug-resistant bacteria. Infect Drug Resist 16:7313\u20137326. https:\/\/doi.org\/10.2147\/idr.S431256","journal-title":"Infect Drug Resist"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01357-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-025-01357-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01357-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:22:34Z","timestamp":1760163754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-025-01357-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":26,"alternative-id":["1357"],"URL":"https:\/\/doi.org\/10.1007\/s12223-025-01357-2","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Mersin University Rectorate Clinical Research Ethics Committee with the decision dated May 10, 2023, and numbered 2023\/321.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}